Health and Fitness Health and Fitness
Fri, May 21, 2010
[ 04:30 AM ] - Market Wire
More Than 100 Presentations and Posters Evaluatin .. ghlighted at Three Major Medical Meetings in June
[ 04:00 AM ] - Market Wire
Seattle Genetics and Millennium to Present Brentu .. al Data at the American Society of Clinical Oncol
[ 03:00 AM ] - Market Wire
ZIOPHARM to Present Further Palifosfamide PICASSO Phase II Results in Oral Session at ASCO
[ 01:00 AM ] - Market Wire
Landmark Randomized Trial Shows Exceptional Clinical Outcomes for Micrus Endovascular Microcoils
Thu, May 20, 2010
[ 11:40 PM ] - Market Wire
Pharming receives D180 List of Outstanding Issues on Rhucin MAA
[ 04:36 PM ] - Market Wire
Exelixis Reports Updated Phase 2 Data for XL184 i .. th Recurrent Glioblastoma to Be Presented at ASCO
[ 04:35 PM ] - Market Wire
Exelixis Reports Encouraging Interim Data from an .. Discontinuation Trial of XL184 in Patients With S
[ 04:34 PM ] - Market Wire
Exelixis Reports Encouraging Interim Data From an .. XL184 With or Without Erlotinib in Patients With
[ 04:32 PM ] - Market Wire
Exelixis Reports Long-Term Phase 1 Results in a C .. ancer Patients Treated With XL184 to be Presented
[ 03:32 PM ] - Market Wire
Alnylama?s ALN-VSP Abstract Published by American Society of Clinical Oncology (ASCO)
[ 03:30 PM ] - Market Wire
Array BioPharma Announces Abstracts Selected for Presentation at 2010 ASCO Annual Meeting
[ 03:00 PM ] - Market Wire
Peregrine to Present Lung, Advanced Breast, and B .. Cancer Clinical Data at 2010 ASCO Annual Meeting
[ 03:00 PM ] - Market Wire
Second Trial with ABRAXANE to Demonstrate Increas .. vival in Patients with Advanced Pancreatic Cancer
[ 02:00 PM ] - Market Wire
The Zacks Small-Cap Profile Features Access Pharmaceuticals and Sanofi-Aventis
[ 02:00 PM ] - Market Wire
Teva Pharmaceutical Industries, AstraZeneca, Merck, SLM Corporation and Nelnet
[ 01:30 PM ] - Market Wire
Orthofix International Launches Three New Sports Medicine Products
[ 01:14 PM ] - Market Wire
NPS Pharmaceuticals to Present at Citi Global Health Care Conference
[ 01:11 PM ] - Market Wire
WellTek to Sponsor National Seminar Series Featur .. reatment of Chronic and Severe Back and Neck Pain
[ 01:10 PM ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at the 2010 .. Investment Research Global Healthcare Conference
[ 01:05 PM ] - Market Wire
Alcon Shareholders Approve Dividend, Elect Directors
[ 01:02 PM ] - Market Wire
Labopharm announces completion of joint venture with Angelini
[ 01:00 PM ] - Market Wire
WellCare to Hold 2010 Annual Meeting of Stockholders on June 10 in Tampa, Florida
[ 11:30 AM ] - Market Wire
Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR
[ 10:45 AM ] - Market Wire
Phase III Study Showed First-Line Maintenance Use .. elihood of People with Follicular Lymphoma Living
[ 09:41 AM ] - Market Wire
Medtronic Announces 2010 Analyst Meeting and Webcast
[ 08:23 AM ] - Market Wire
Magellan Health Services Offers E-Courses for Providers, Consumers and Families
[ 08:00 AM ] - Market Wire
Community Health Systems to Participate in Citi I .. stment Research 2010 Global Healthcare Conference
[ 07:23 AM ] - Market Wire
Rosetta Genomics To Host First Quarter 2010 Conference Call on Thursday, May 27, 2010
[ 06:37 AM ] - Market Wire
St. Jude Medical neemt LightLab Imaging over
[ 06:36 AM ] - Market Wire
St. Jude Medical adquiere LightLab Imaging

St. Jude Medical adquiere LightLab Imaging


Published on 2010-05-20 06:41:06 - Market Wire
  Print publication without navigation


ST. PAUL, Minnesota & WESTFORD, Massachussets--([ BUSINESS WIRE ])--St. Jude Medical, Inc. (NYSE:STJ), empresa mundial de dispositivos m©dicos, y LightLab Imaging, Inc. han suscrito un acuerdo definitivo por el que St. Jude Medical adquirir LightLab, filial de Goodman Co., Ltd. (JASDAQ: 7535) por aproximadamente $90 millones en efectivo.

LightLab es pionero y lder en el desarrollo de tomografa de coherencia ptica (OCT en sus siglas en ingl©s), una tecnologa de imgenes coronarias por diagnstico de alta resolucin que ayuda a los m©dicos en el tratamiento de enfermedades cardiovasculares.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources